Robert W. Talley
About
In The Last Decade
Robert W. Talley
51 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 722
- Pathology and Forensic Medicine 695
- Molecular Biology 456
- Surgery 340
Countries citing papers authored by Robert W. Talley
This map shows the geographic impact of Robert W. Talley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Talley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Talley more than expected).
Fields of papers citing papers by Robert W. Talley
This network shows the impact of papers produced by Robert W. Talley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Talley. The network helps show where Robert W. Talley may publish in the future.
Co-authorship network of co-authors of Robert W. Talley
This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Talley. A scholar is included among the top collaborators of Robert W. Talley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Talley. Robert W. Talley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 11 | |
| 3 | Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study. | 1 |
| 4 | Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma. | 3 |
| 5 | Chemotherapy of Metastatic Renal Adenocarcinoma with a Five- Drug Regimen* | 3 |
| 6 | 20 | |
| 7 | Diethylstilbestrol: recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cancer Group. | 84 |
| 8 | 28 | |
| 9 | 89 | |
| 10 | 22 | |
| 11 | 13 | |
| 12 | The hypocalcemic effects of actinomycin F and mithramycin. | 1 |
| 13 | 8 | |
| 14 | Observations on the mechanism of hemorrhagic toxicity in mithramycin (NSC 24559) therapy. | 27 |
| 15 | Intrathecal Cytosine Arabinoside in Hodgkin's Disease With Central Nervous System Manifestations | 1 |
| 16 | 40 | |
| 17 | Carcinoma Of The Lung Occurring In Patient With Carotid Body Tumor: Case Report | 1 |
| 18 | 23 | |
| 19 | 43 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.